The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Crosstalk via the NF-κB signaling system
Open accessAbstract
The nuclear factor kappaB (NF-kappaB) family of transcription factors consists of 15 possible dimers whose activity is controlled by a family of inhibitor proteins, known as IkappaBs. A variety of cellular stimuli, many of them transduced by members of the tumor necrosis factor receptor (TNFR) superfamily, induce degradation of IkappaBs to activate an overlapping subset of NF-kappaB dimers. However, generation and stimulus-responsive activation of NF-kappaB dimers are intimately linked via various cross-regulatory mechanisms that allow crosstalk between different signaling pathways through the NF-kappaB signaling system. In this review, we summarize these mechanisms and discuss physiological and pathological consequences of crosstalk between apparently distinct inflammatory and developmental signals. We argue that a systems approach will be valuable for understanding questions of specificity and emergent properties of highly networked cellular signaling systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NF-κB translocated into the nucleus activates the transcription of target genes (Basak and Hoffmann 2008).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Basak and Hoffmann 2008
In the citing paper
“The canonical activation pathway is triggered through the site-specific phosphorylation by an IκB-kinase (IKK) complex in response to microbes, and proinflammatory cytokines.”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Basak and Hoffmann 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638 · cited 1×
“In general, the catalytic activity of IKK2 is required for canonical signaling [8,9].”
BackgroundNuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
IκB: a Specific Inhibitor of the NF-κB Transcription Factor
Baeuerle, P. A., & Baltimore, D. (1988) · Science · doi:10.1126/science.3140380 · Cited by 2,154
The IκB-NF-κB Signaling Module: Temporal Control and Selective Gene Activation
Hoffmann, A., Levchenko, A., Scott, M. L., & Baltimore, D. (2002) · Science · doi:10.1126/science.1071914 · Cited by 1,890
Self-citationEmbryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB
Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S., & Baltimore, D. (1995) · Nature · doi:10.1038/376167a0 · Cited by 1,828
Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway
Senftleben, U., Cao, Y., Xiao, G., Greten, F. R., Krähn, G. M., Bonizzi, G., Chen, Y., Hu, Y., Fong, A., Sun, S., et al. (2001) · Science · doi:10.1126/science.1062677 · Cited by 1,361
Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses
Sha, W. C., Liou, H.-C., TUOMANEN, E. I., & Baltimore, D. (1995) · Cell · doi:10.1016/0092-8674(95)90415-8 · Cited by 1,158
Baeuerle, P. A., & Baltimore, D. (1988) · Cell · doi:10.1016/0092-8674(88)90382-0 · Cited by 1,130
Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma
Keats, J. J., Fonseca, R., Chesi, M., Schop, R., Baker, A., Chng, W.-J., Van Wier, S., Tiedemann, R., Shi, C.-X., Sebag, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.003 · Cited by 983
Annunziata, C. M., Davis, R. E., Demchenko, Y., Bellamy, W., Gabrea, A., Zhan, F., Lenz, G., Hanamura, I., Wright, G., Xiao, W., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.004 · Cited by 952
The Lymphotoxin-β Receptor Induces Different Patterns of Gene Expression via Two NF-κB Pathways
Dejardin, E., Droin, N. M., Delhase, M., Haas, E., Cao, Y., Makris, C., Li, Z., Karin, M., Ware, C. F., & Green, D. R. (2002) · Immunity · doi:10.1016/s1074-7613(02)00423-5 · Cited by 923
Circuitry of nuclear factor κB signaling
Hoffmann, A., & Baltimore, D. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00375.x · Cited by 907
Self-citationNF-κB-Inducing Kinase Regulates the Processing of NF-κB2 p100
Xiao, G., Harhaj, E. W., & Sun, S. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00187-3 · Cited by 836
Organogenesis of lymphoid tissues
Mebius, R. E. (2003) · Nature reviews. Immunology · doi:10.1038/nri1054 · Cited by 747
Fütterer, A., Mink, K., Luz, A., Kosco‐Vilbois, M. H., & Pfeffer, K. (1998) · Immunity · doi:10.1016/s1074-7613(00)80588-9 · Cited by 732
Köntgen, F., Grumont, R. J., Strasser, A., Metcalf, D., Li, R., Tarlinton, D. M., & Gerondakis, S. (1995) · Genes & Development · doi:10.1101/gad.9.16.1965 · Cited by 727
OSTEOIMMUNOLOGY: Interplay Between the Immune System and Bone Metabolism
Walsh, M. C., Kim, N., Kadono, Y., Rho, J., Lee, S. Y., Lorenzo, J., & Choi, Y. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090646 · Cited by 724
IκB kinase complexes: gateways to NF-κB activation and transcription
Scheidereit, C. (2006) · Oncogene · doi:10.1038/sj.onc.1209934 · Cited by 668
DEVELOPMENT AND MATURATION OF SECONDARY LYMPHOID TISSUES
Fu, Y., & Chaplin, D. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.399 · Cited by 615
Achieving Stability of Lipopolysaccharide-Induced NF-κB Activation
Covert, M. W., Leung, T., Gaston, J. E., & Baltimore, D. (2005) · Science · doi:10.1126/science.1112304 · Cited by 612
The Crystal Structure of the IκBα/NF-κB Complex Reveals Mechanisms of NF-κB Inactivation
Huxford, T., Huang, D.-B., Malek, S., & Ghosh, G. (1998) · Cell · doi:10.1016/s0092-8674(00)81699-2 · Cited by 587
Stimulus Specificity of Gene Expression Programs Determined by Temporal Control of IKK Activity
Werner, S. L., Barken, D. M., & Hoffmann, A. (2005) · Science · doi:10.1126/science.1113319 · Cited by 509
Self-citationZhang, Y.-H., Heulsmann, A., Tondravi, M. M., Mukherjee, A., & Abu‐Amer, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008198200 · Cited by 503
Yamashita, T., Yao, Z., Li, F., Zhang, Q., Badell, I. R., Schwarz, E. M., Takeshita, S., Wagner, E. F., Noda, M., Matsuo, K., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610701200 · Cited by 414
Zabel, U., & Baeuerle, P. A. (1990) · Cell · doi:10.1016/0092-8674(90)90806-p · Cited by 413
Defective Lymphotoxin-β Receptor-Induced NF-κB Transcriptional Activity in NIK-Deficient Mice
Li, Y., Wu, L., Wesche, H., Arthur, C. D., White, J. M., Goeddel, D. V., & Schreiber, R. D. (2001) · Science · doi:10.1126/science.1058453 · Cited by 408
A Fourth IκB Protein within the NF-κB Signaling Module
Basak, S., Kim, H., Kearns, J. D., Tergaonkar, V., O'Dea, E. L., Werner, S. L., Benedict, C. A., Ware, C. F., Ghosh, G., Verma, I. M., et al. (2007) · Cell · doi:10.1016/j.cell.2006.12.033 · Cited by 404
Self-citationI kappa B epsilon, a novel member of the IκB family, controls RelA and cRel NF‐κB activity
Whiteside, S. T., Epinat, J.-C., Rice, N. R., & Israël, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.6.1413 · Cited by 396
Pomerantz, J. L., & Baltimore, D. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00697-4 · Cited by 395
Dendritic Cell Development and Survival Require Distinct NF-κB Subunits
Ouaaz, F., Arron, J. R., Zheng, Y., Choi, Y., & Beg, A. A. (2002) · Immunity · doi:10.1016/s1074-7613(02)00272-8 · Cited by 389
Lymph Node Fibroblastic Reticular Cells Construct the Stromal Reticulum via Contact with Lymphocytes
Katakai, T., Hara, T., Sugai, M., Gonda, H., & Shimizu, A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040254 · Cited by 361
Bonizzi, G., Bébien, M., Otero, D. C., Johnson-Vroom, K. E., Cao, Y., Vu, D., Jegga, A. G., Aronow, B. J., Ghosh, G., Rickert, R. C., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600391 · Cited by 338
Genetic analysis of NF‐κB/Rel transcription factors defines functional specificities
Hoffmann, A., Leung, T., & Baltimore, D. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg534 · Cited by 337
Self-citationPhosphorylation of IκBα Precedes but Is Not Sufficient for Its Dissociation from NF-κB
DiDonato, J. A., Mercurio, F., & Karin, M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1302 · Cited by 337
Distribution of NF-κB-binding sites across human chromosome 22
Martone, R., Euskirchen, G. M., Bertone, P., Hartman, S. E., Royce, T. E., Luscombe, N. M., Rinn, J. L., Nelson, F. K., Miller, P. L., Gerstein, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135255100 · Cited by 310
Lymph Node Genesis Is Induced by Signaling through the Lymphotoxin β Receptor
Rennert, P. D., James, D. F., Mackay, F., Browning, J. L., & Hochman, P. S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80589-0 · Cited by 297
Xiao, G., Fong, A., & Sun, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401428200 · Cited by 296
Molecular mechanisms of constitutive NF-κB/Rel activation in Hodgkin/Reed-Sternberg cells
Krappmann, D., Emmerich, F., Kordes, U., Scharschmidt, E., Dörken, B., & Scheidereit, C. (1999) · Oncogene · doi:10.1038/sj.onc.1202351 · Cited by 271
Beyond IκBs: alternative regulation of NF‐KB activity
Neumann, M., & Naumann, M. (2007) · The FASEB Journal · doi:10.1096/fj.06-7615rev · Cited by 267
Alcamo, E., Mizgerd, J. P., Horwitz, B. H., Bronson, R. T., Beg, A. A., Scott, M. L., Doerschuk, C. M., Hynes, R. O., & Baltimore, D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1592 · Cited by 259
Boothby, M. R., Mora, A. L., Scherer, D. C., Brockman, J. A., & Ballard, D. W. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.11.1897 · Cited by 243
Ramakrishnan, P., Wang, W., & Wallach, D. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.009 · Cited by 232
Kearns, J. D., Basak, S., Werner, S. L., Huang, C., & Hoffmann, A. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200510155 · Cited by 230
Self-citationChiu, A., Xu, W., He, B., Dillon, S. R., Gross, J. A., Sievers, E. L., Qiao, X., Santini, P. A., Hyjek, E. M., Lee, J.-W., et al. (2006) · Blood · doi:10.1182/blood-2006-04-015958 · Cited by 229
Weih, D., Yilmaz, Z. B., & Weih, F. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.1909 · Cited by 220
Lymphotoxin and LIGHT signaling pathways and target genes
Schneider, K., Potter, K. G., & Ware, C. F. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00206.x · Cited by 218
Yilmaz, Z. B., Weih, D. S., Sivakumar, V., & Weih, F. (2002) · The EMBO Journal · doi:10.1093/emboj/cdg004 · Cited by 218
Coordinated binding of NF-κB family members in the response of human cells to lipopolysaccharide
Schreiber, J., Jenner, R. G., Murray, H. L., Gerber, G. K., Gifford, D. K., & Young, R. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510996103 · Cited by 181
Defective Peyer's patch organogenesis in mice lacking the 55-kD receptor for tumor necrosis factor.
Neumann, B., Luz, A., Pfeffer, K., & Holzmann, B. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.1.259 · Cited by 177
Müller, J. R., & Siebenlist, U. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210768200 · Cited by 177
Basak, S., Shih, V. F.-S., & Hoffmann, A. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01469-07 · Cited by 138
Self-citationRebholz, B., Haase, I., Eckelt, B., Paxian, S. A., Flaig, M. J., Ghoreschi, K., Nedospasov, S. A., Mailhammer, R., Debey‐Pascher, S., Schultze, J. L., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.05.024 · Cited by 138
Lymphotoxin and lipopolysaccharide induce NF‐κB‐p52 generation by a co‐translational mechanism
Mordmüller, B. G., Krappmann, D., Esen, M., Wegener, E., & Scheidereit, C. (2003) · EMBO Reports · doi:10.1038/sj.embor.embor710 · Cited by 132
Zheng, Y., Vig, M., Lyons, J., Parijs, L. V., & Beg, A. A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021610 · Cited by 128
Dejardin, E., Bonizzi, G., Bellahcène, A., Castronovo, V., Merville, M.-P., & Bours, V. (1995) · PubMed · Cited by 124
A New Member of the IκB Protein Family, IκBε, Inhibits RelA (p65)-Mediated NF-κB Transcription
Li, Z., & Nabel, G. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.10.6184 · Cited by 117
Lo, J. C., Basak, S., James, E. S., Quiambo, R. S., Kinsella, M., Alegre, M., Weih, F., Franzoso, G., Hoffmann, A., & Fu, Y. (2005) · Blood · doi:10.1182/blood-2005-06-2452 · Cited by 104
Self-citationRequirement for the NF-κB Family Member RelA in the Development of Secondary Lymphoid Organs
Alcamo, E., Hacohen, N., Schulte, L. C., Rennert, P. D., Hynes, R. O., & Baltimore, D. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011885 · Cited by 104
Wang, J., Wang, X., Hussain, S., Zheng, Y., Sanjabi, S., Ouaaz, F., & Beg, A. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6777 · Cited by 92
Wang, Y.-G., Kim, K. D., Wang, J. H., Yu, P., & Fu, Y. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6997 · Cited by 70
de Wit, H., Dokter, W., Koopmans, S., Lummen, C., van der Leij, M., Smit, J., & Vellenga, E. (1998) · Leukemia · doi:10.1038/sj.leu.2400950 · Cited by 32
Cited by
Sorted by citations
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638
Ros and ros-mediated cellular signaling
Zhang, J., Wang, X., Vikash, V., Ye, Q., Wu, D., Liu, Y., & Dong, W. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/4350965 · Cited by 1,980
Mitchell, S. A., Vargas, J. D., & Hoffmann, A. (2016) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1331 · Cited by 1,057
Self-citationSabat, R., Grütz, G., Warszawska, K., Kirsch, S., Witte, E., Wolk, K., & Geginat, J. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.09.002 · Cited by 977
Sanz, A. B., Sánchez-Niño, M. D., Ramos, A. M., Moreno, J. A., Santamaria, B., Ruiz‐Ortega, M., Egido, J., & Ortíz, A. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010020218 · Cited by 581
Metadata
- Authors
- Basak, S., & Hoffmann, A.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Basak, Soumen
- Hoffmann, Alexander
- Venue
- Cytokine & Growth Factor Reviews
- Publisher
- Elsevier BV
- Published
- 2008-06
- Volume
- 19
- Issue
- 3-4
- Pages
- 187-197
- ISSN
- 1359-6101 (ISSN-L)
- PMC
- PMC2675004
- OpenAlex
- W2054072076
- Cited by
- 177
- References
- 64
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 5 · 2023: 6 · 2022: 2 · 2021: 9 · 2020: 10 · 2019: 5 · 2018: 13 · 2017: 6 · 2016: 10 · 2015: 8 · 2014: 12 · 2013: 13 · 2012: 8
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Cytokine & Growth Factor Reviews (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (P01GM071862, R01GM071573)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- NF-κB signaling, signaling crosstalk, IκB degradation, TNF receptor superfamily, inflammatory signaling, developmental signaling
- MeSH terms
- Animals, Immunity, Inflammation, Lymphoid Tissue, Signal Transduction, NF-kappa B, Receptors, Tumor Necrosis Factor, Growth and Development, Mice, Transcription Factor RelA, NF-kappa B p50 Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
